Leap Therapeutics
LPTX
$2.07
Share price
-1.90%
Change (1 day)
204.41%
Change (1 year)
Categories
Leap Therapeutics (LPTX) - Cash on Hand
Cash on Hand as of March 2024 : $54.92 M
According to Leap Therapeutics
's latest financial reports the company has $54.92 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Leap Therapeutics - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $65.5 M | -43% |
| 2021-12-31 | $0.11 B | 120.69% |
| 2020-12-31 | $52.07 M | 1238.24% |
| 2019-12-31 | $3.89 M | -76.11% |
| 2018-12-31 | $16.28 M | -36.73% |
| 2017-12-31 | $25.73 M | 3145.52% |
| 2016-12-31 | $0.79 M | 95.8% |
| 2015-12-31 | $0.4 M | -99.12% |
| 2014-12-31 | $46.18 M | 143.12% |
| 2013-12-31 | $18.99 M | 23.97% |
| 2012-12-31 | $15.32 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 476.79% | 🇺🇸 USA |